Language
TW
Leadgene Leadgene
SARS-CoV-2 Nucleocapsid Protein, His-SUMO Tag, HEK293
More Images
Catalog Number

LDG006PVM

More Documents
Loading package & price...
  • Specifications
    • Species of Origin

      SARS-CoV-2

      Expression System

      HEK293

    • Affinity Tag

      His-SUMO Tag (N-term)

      Storage Buffer

      Lyophilized from a 0.2 µm filtered solution of PBS, pH 7.4.

    • Purity

      >98% as determined by SDS-PAGE analysis.

      Molecular weight

      The protein has a calculated MW of 57.17 kDa.
      The protein migrates as 63-75 kDa under reducing condition (SDS-PAGE analysis).

    • Form

      Lyophilized

  • Background
    • Background

      Coronaviruses (Delta B1.617.2 Variant) are enveloped positive-sense RNA viruses. Spike protein on the viral envelope and the cognate receptor on the surface of host cells that are essential for entry into host cells upon receptor binding and membrane fusion. Spike proteins are target for neutralization antibody, and mediate membrane fusion and virus entry.Trimeric spike protein is about 180 kDa, and contains two subunits, S1 and S2, mediating attachment and membrane fusion.

      Synonyms

      Nucleoprotein, N, Nucleocapsid protein, NC Protein N

    • Uniprot ID

      #P0DTC9

      Sequence Note

      Met1-Ala419

  • Instruction
    • Reconstitution

      It is recommended to reconstitute the lyophilized protein in sterile H₂O to a concentration not less than 200 μg/mL and incubate the stock solution for at least 20 min to ensure sufficient re-dissolved.

      Shipping

      The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

    • Stability & Storage

      This product is stable after storage at:

      • -20°C for 12 months in lyophilized state from date of receipt.
      • -20°C or -80°C for 1 month under sterile conditions after reconstitution.

      Avoid repeated freeze/thaw cycles.

  • Image
    Multi-cycle kinetic analysis of Human anti-SARS-CoV & CoV-2 NP Antibody (IgG) to Human SARS-CoV-2 Nucleocapsid protein by using Biacore T200.

    Multi-cycle kinetic analysis of Human anti-SARS-CoV & CoV-2 NP Antibody (IgG) to Human SARS-CoV-2 Nucleocapsid protein by using Biacore T200.

    ELISA titration of Human anti-SARS-CoV & CoV-2 NP Antibody (A. IgG; B. IgA; C. IgM antibody).

    ELISA titration of Human anti-SARS-CoV & CoV-2 NP Antibody (A. IgG; B. IgA; C. IgM antibody).

    WB analysis of recombinant Human SARS-CoV-2 nucleocapsid protein. Lane 1: Human anti-SARS-CoV & CoV-2 NP Antibody (IgG), 0.5 μg/mL (Leadgene cat. 17901) Lane 2: Human anti-SARS-CoV & CoV-2 NP Antibody (IgM), 0.5 μg/mL (Leadgene cat. 18301)

    WB analysis of recombinant Human SARS-CoV-2 nucleocapsid protein.
    Lane 1: Human anti-SARS-CoV & CoV-2 NP Antibody (IgG), 0.5 μg/mL (Leadgene cat. 17901)
    Lane 2: Human anti-SARS-CoV & CoV-2 NP Antibody (IgM), 0.5 μg/mL (Leadgene cat. 18301)

    SDS-PAGE analysis of recombinant Human SARS-CoV-2 nucleocapsid protein.

    SDS-PAGE analysis of recombinant Human SARS-CoV-2 nucleocapsid protein.

    1
    /
    4
    Total   (4)
  • Review

    Help others learn more about this product. Use the link below to share your experience.

  • Publication
  • Datasheet & Documents
    MSDS
    Manual
    1
    /
    1

Disclaimer:For Research Use or Further Manufacturing Only.

This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.